Clinical trial shows tezepelumab controls asthma in diverse patient population

The premise of PASSAGE was to focus on underrepresented populations, and to gather more evidence so that we can be more confident in using tezepelumab in these patients: Dr….

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *